Impact of complete cytogenetic response on survival in patients with myelodysplastic syndromes.

被引：0
|
作者：
Urrutia, Samuel
Sasaki, Koji
Kantarjian, Hagop M.
Jabbour, Elias
Chien, Kelly Sharon
Hammond, Danielle
Bueso-Ramos, Carlos E.
Khoury, Joseph
Patel, Keyur P.
Montalban-Bravo, Guillermo
Wei, Yue
Colla, Simona
Short, Nicholas James
Daver, Naval Guastad
Borthakur, Gautam
Kadia, Tapan M.
Pierce, Sherry
Wierda, William G.
Garcia-Manero, Guillermo
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6567
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cytogenetic of myelodysplastic syndromes.
    Lai, JL
    Fenaux, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (07): : 550 - 555
  • [2] A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes.
    Della Porta, Matteo G.
    Malcovati, Luca
    Travaglino, Erica
    Pascutto, Cristiana
    Maffioli, Margherita
    Invernizzi, Rosangela
    Cazzola, Mario
    BLOOD, 2007, 110 (11) : 723A - 723A
  • [3] Prognostic relevance of cytogenetic subgroups in 357 patients with myelodysplastic syndromes.
    Haase, D
    Schanz, J
    Wulich, J
    Schoch, C
    Freund, M
    Haferlach, T
    Wormann, B
    Staib, P
    Lentini, G
    Bartels, H
    Geissler, RG
    Germing, U
    Dorges, U
    Fonatsch, C
    Hiddemann, W
    BLOOD, 1997, 90 (10) : 2232 - 2232
  • [4] Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents
    Jabbour, Elias
    Strati, Paolo
    Cabrero, Monica
    O'Brien, Susan
    Ravandi, Farhad
    Bueso-Ramos, Carlos
    Wei, Qiao
    Hu, Jianhua
    Abi Aad, Simon
    Short, Nicholas J.
    Dinardo, Courtney
    Daver, Naval
    Kadia, Tapan
    Wierda, William
    Wei, Yue
    Colla, Simona
    Borthakur, Gautam
    Cortes, Jorge
    Estrov, Zeev
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) : 351 - 358
  • [5] Recombinant erythropoietin and survival in myelodysplastic syndromes.
    Musto, P
    BLOOD, 2005, 106 (11) : 713A - 713A
  • [6] Retrospective analysis of effects of transfusion status on response to decitabine and survival in patients with myelodysplastic syndromes.
    Kadia, T. M.
    Garcia-Manero, G.
    Kantarjian, H.
    Pemmaraju, N.
    Stein, K.
    Teng, A.
    Cortes, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Survival Benefits of Complete Cytogenetic Response in Patients with Newly Diagnosed Myelodysplastic Syndrome
    Azevedo, Roberta Santos
    Kantarjian, Hagop M.
    Jabbour, Elias
    Kanagal-Shamanna, Rashmi
    Chien, Kelly S.
    Hammond, Danielle
    Urrutia, Samuel
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Montalban-Bravo, Guillermo
    Short, Nicholas J.
    Daver, Naval
    Borthakur, Gautam
    Kadia, Tapan M.
    BLOOD, 2024, 144 : 6727 - 6727
  • [8] Myelodysplastic syndromes. Incidence and survival in Republic of Armenia
    Daghbashyan, S.
    Sahakyan, L.
    Kabasakalyan, E.
    LEUKEMIA RESEARCH, 2013, 37 : S143 - S143
  • [9] Myelodysplastic syndromes. Incidence and survival in Republic of Armenia
    Daghbashyan, S.
    Sahakyan, L.
    Kabasakalyan, E.
    LEUKEMIA RESEARCH, 2013, 37 : S41 - S41
  • [10] Myelodysplastic syndromes.
    Miller K.B.
    Current Treatment Options in Oncology, 2000, 1 (1) : 63 - 69
12345